aquila biolabs

Name

aquila biolabs

Legal name

aquila biolabs GmbH

Website

https://aquila-biolabs.de

Company type

Private

Founded year

2014

Operating status

Acquired

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Bioprocessing Laboratory Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826), Industrial Instruments For Measurement, Display, And Control (3823)

akta.pro primary industry

Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG)

akta.pro secondary industries

Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF), Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES) (HLAAAJAE), General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens) (HLAGAIAC)

Keywords

• Bioprocessing monitoring instruments
• Continuous glucose quantification
• Laboratory fermentation analytics
• Bioreactor monitoring systems
• Laboratory information systems

Headquarters

HQ city

Baesweiler

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Laboratory Instrumentation and Bioprocessing Equipment Sales: aquila biolabs generated revenue through the sale of specialized laboratory instruments and bioprocessing equipment, including CGQ, CGQ BioR, and LIS products. The company operated on a business-to-business model, selling to research institutions and biotech/pharma companies with standard terms including retained ownership until full payment.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

aquila biolabs developed and sold specialized laboratory instruments for bioprocess monitoring, including the CGQ continuous glucose quantifier, the CGQ BioR bioreactor-integrated monitoring system, and the LIS laboratory information management software. Products were sold directly to research institutions and biotech/pharmaceutical companies for use in shake-flask fermentation and bioprocessing research environments.

Product overview

aquila biolabs was a German biotech/life sciences instrumentation company that offered a portfolio of products including CGQ, CGQ BioR (likely a bioreactor-specific variant), and LIS (Laboratory Information System). In April 2021, aquila biolabs was acquired by Scientific Bioprocessing, Inc. (SBI) and all products and content were migrated to the SBI website. The products appear to serve the bioprocessing, research, and laboratory data management markets.

Differentiator

Problem solved

Functional benefit

Brands

• CGQ: Cell Growth Quantifier - laboratory equipment product line
• CGQ BioR
• LIS

Products and services

• CGQ Continuous Glucose Quantifier — a proprietary laboratory instrument for continuous, real-time glucose monitoring in bioprocessing and shake-flask fermentation environments, sold to research institutions and biotech/pharma companies.
• CGQ BioR Bioreactor-integrated version of the CGQ continuous glucose monitoring instrument, designed to be directly integrated with bioreactors for inline continuous glucose quantification in bioprocess development.
• LIS (Laboratory Information System) Laboratory information management software for tracking, capturing, and analyzing data generated by aquila biolabs instruments and other laboratory workflows, licensed to customers subject to full payment of the agreed consideration.

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Scientific Bioprocessing, Inc. (SBI)flagshipStrategic or Co-development Partner · 30 April 2021In 2021, aquila biolabs was acquired by Scientific Bioprocessing, Inc. (SBI). All content from the aquila biolabs webpage, including products (CGQ, CGQ BioR, LIS), publications, and customer success stories, was migrated to the SBI website (scientificbio.com). The acquisition significantly expanded SBI's capabilities and talented team.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Cytiva: Large bioprocess supplier (formerly GE Biopharma) offering bioreactors, sensors, and PAT tools; competes at the integrated bioprocess platform level.
• Sartorius AG: Global bioprocess equipment leader offering bioreactors, PAT sensors, and process analytics; competes with CGQ as part of a much broader upstream/downstream bioprocessing portfolio.
• Applikon Biotechnology (Getinge): Supplies laboratory and pilot-scale bioreactor systems with integrated monitoring; competes in the same shake-flask-to-bioreactor bioprocess workflow as aquila's products.
• Mettler-Toledo International Inc. Global lab and process analytical instrument manufacturer; relevant overlap in process analytics and laboratory sensors used in bioprocess monitoring.
• Eppendorf AG: Major lab and bioprocess instrument manufacturer (bioreactors, shakers, sensors); overlaps with CGQ in shake-flask fermentation monitoring and bioreactor control.

Direct peers

• PreSens Precision Sensing GmbH: Specialist in non-invasive optical chemical sensors for bioprocess monitoring (O2, pH, glucose); comparable niche positioning to CGQ with overlapping customer base in shake-flask and bioreactor applications.
• Hamilton Company: Manufactures in-line process sensors (pH, DO, glucose) for bioreactors; directly comparable PAT/continuous-monitoring technology competing with CGQ BioR.
• Scientific Bioprocessing, Inc. (SBI): Parent company post-2021; builds bioprocess monitoring and sensor products for shake flasks and bioreactors — directly comparable product line to CGQ/CGQ BioR, now consolidated under one roof.
• Broadley-James Corporation: Supplier of bioprocess sensors and probes (pH, DO, optical) for bioreactor applications; directly comparable single-purpose sensor focus to CGQ BioR.

Emerging players

• Hello Bio: Smaller life-science tools provider active in bioprocess and cell-culture research consumables; partial overlap with aquila's research/academic customer segment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/aquila-biolabs

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about aquila biolabs